Following surface engineering of IL-2, the resulting exosomes’ miR profiles underwent substantial changes that activated CD8 + T cells and decreased the expression of PD-L1 in melanoma cells via differentially expressed miRs [142]. The gene discussed is CD274; the disease is melanoma.